Evidence map›Paper›PMID 22945239›Full record

ArticleBiometals : an international journal on the role of metal ions in biology, biochemistry, and medicine2012

Competition of zinc ion for the [2Fe-2S] cluster binding site in the diabetes drug target protein mitoNEET.

Guoqiang Tan, Aaron P Landry, Ruili Dai, Li Wang, Jianxin Lu, Huangen Ding

Open access · greenAbstract read
In one paragraph

Article in Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Article
  3. Zinc Toxicity and Iron-Sulfur Cluster Biogenesis inApplied and environmental microbiology · 2019
    Article
  4. Article
  5. Accessory NUMM (NDUFS6) subunit harbors a Zn-binding site and is essential for biogenesis of mitochondrial complex I.Proceedings of the National Academy of Sciences of the United States of America · 2015
    Article
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Guoqiang TanLaboratory of Molecular Medicine, Wenzhou Medical College, Wenzhou, 325035, Zhejiang, People's Republic of China.
Aaron P Landry
Ruili Dai
Li Wang
Jianxin Lu
Huangen Ding
Wenzhou Medical University · CNLouisiana State University · US

Funding

Nitric Oxide Cytotoxicity and Iron-Sulfur ProteinsR01CA107494 · NCI · LOUISIANA STATE UNIV A&M COL BATON ROUGE · PI DING, HUANGEN · 2005 to 2009
$1.1M
NCI NIH HHS R01 CA107494NCI NIH HHS R01CA107494
6 · The paper itself

Abstract

Human mitochondrial protein mitoNEET is a novel target of type II diabetes drug pioglitazone, and contains a redox active [2Fe-2S] cluster that is hosted by a unique ligand arrangement of three cysteine and one histidine residues. Here we report that zinc ion can compete for the [2Fe-2S] cluster binding site in human mitoNEET and potentially modulate the physiological function of mitoNEET. When recombinant mitoNEET is expressed in Escherichia coli cells grown in M9 minimal media, purified mitoNEET contains very little or no iron-sulfur clusters. Addition of exogenous iron or zinc ion in the media produces mitoNEET bound with a [2Fe-2S] cluster or zinc, respectively. Mutations of the amino acid residues that hosting the [2Fe-2S] cluster in mitoNEET diminish the zinc binding activity, indicating that zinc ion and the [2Fe-2S] cluster may share the same binding site in mitoNEET. Finally, excess zinc ion effectively inhibits the [2Fe-2S] cluster assembly in mitoNEET in E. coli cells, suggesting that zinc ion may impede the function of mitoNEET by blocking the [2Fe-2S] cluster assembly in the protein.

Indexed as

Binding, CompetitiveDiabetes Mellitus, Type 2HumansIonsIron-Sulfur ProteinsMitochondrial ProteinsMolecular Targeted TherapyPioglitazoneThiazolidinedionesZincCISD1 protein, humanIonsIron-Sulfur ProteinsMitochondrial ProteinsPioglitazoneThiazolidinedionesZinc

Identifiers

PMID22945239
PMCPMC3822609
OpenAlexW2149901862

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.